Ubs Group Ag Intercept Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$9.99 - $18.71 $16.4 Million - $30.7 Million	1,639,717 Added 120.61%	2,999,188 $55.6 Million
Q2 2023 Aug 11, 2023	BUY	$9.17 - $19.29 $11.3 Million - $23.8 Million	1,236,323 Added 1003.93%	1,359,471 $15 Million
Q1 2023 May 12, 2023	SELL	$12.53 - $21.71 $1.04 Million - $1.81 Million	-83,170 Reduced 40.31%	123,148 $1.65 Million
Q4 2022 Feb 08, 2023	BUY	$11.61 - $16.11 $1.72 Million - $2.39 Million	148,293 Added 255.57%	206,318 $2.55 Million
Q3 2022 Nov 10, 2022	SELL	$12.21 - $19.7 $430,585 - $694,720	-35,265 Reduced 37.8%	58,025 $809,000
Q2 2022 Aug 10, 2022	SELL	$11.23 - $19.59 $956,683 - $1.67 Million	-85,190 Reduced 47.73%	93,290 $1.29 Million
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $489,582 - $651,434	36,618 Added 25.81%	178,480 $2.9 Million
Q4 2021 Feb 14, 2022	SELL	$14.28 - $19.53 $1.7 Million - $2.33 Million	-119,337 Reduced 45.69%	141,862 $2.31 Million
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $1.83 Million - $2.88 Million	140,747 Added 116.85%	261,199 $3.88 Million
Q2 2021 Aug 13, 2021	SELL	$15.46 - $24.5 $255,832 - $405,426	-16,548 Reduced 12.08%	120,452 $2.41 Million
Q1 2021 May 12, 2021	BUY	$19.33 - $37.75 $2.32 Million - $4.53 Million	119,961 Added 704.04%	137,000 $3.16 Million
Q4 2020 Feb 11, 2021	SELL	$24.48 - $42.47 $40,171 - $69,693	-1,641 Reduced 8.78%	17,039 $421,000
Q3 2020 Nov 12, 2020	SELL	$39.09 - $53.44 $1.44 Million - $1.97 Million	-36,794 Reduced 66.33%	18,680 $775,000
Q2 2020 Jul 31, 2020	SELL	$46.7 - $92.04 $89,570 - $176,532	-1,918 Reduced 3.34%	55,474 $2.66 Million
Q1 2020 May 01, 2020	SELL	$48.35 - $118.68 $701,558 - $1.72 Million	-14,510 Reduced 20.18%	57,392 $3.61 Million
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $6.51 Million - $14.1 Million	-113,423 Reduced 61.2%	71,902 $8.91 Million
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $5.72 Million - $7.85 Million	97,505 Added 111.03%	185,325 $12.3 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $2.73 Million - $4.23 Million	35,047 Added 66.41%	87,820 $6.99 Million
Q1 2019 May 14, 2019	SELL	$91.83 - $120.68 $1.92 Million - $2.52 Million	-20,875 Reduced 28.34%	52,773 $5.9 Million
Q4 2018 Feb 14, 2019	SELL	$85.79 - $126.46 $450,654 - $664,294	-5,253 Reduced 6.66%	73,648 $7.42 Million
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $1.4 Million - $2.01 Million	15,776 Added 24.99%	78,901 $9.97 Million
Q2 2018 Aug 14, 2018	SELL	$60.0 - $85.67 $8.59 Million - $12.3 Million	-143,175 Reduced 69.4%	63,125 $5.3 Million
Q1 2018 May 15, 2018	BUY	$52.72 - $67.25 $826,386 - $1.05 Million	15,675 Added 8.22%	206,300 $12.7 Million
Q4 2017 Feb 14, 2018	BUY	$58.2 - $72.76 $444,066 - $555,158	7,630 Added 4.17%	190,625 $11.1 Million
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $2.18 Million - $4.54 Million	38,221 Added 26.4%	182,995 $10.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	40,680 Added 39.08%	144,774 $17.5 Million
Q1 2017 Nov 14, 2017	BUY	N/A	104,094	104,094 $11.8 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account